Autopsy report · NCT01921829

Protocolized Diuretic Strategy in Cardiorenal Failure

“Due to futility due to lower than expected recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 2 years before it stopped.
• 19 participants enrolled.
• Results were posted on the registry 1 year 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Kelly V. Liang, MD

Sponsor type

University, hospital or other

Conditions

Cardiac Failure; Renal Failure; Kidney Failure

Interventions

Protocolized Diuretic Strategy

Participants

19

Sites

1

Countries

United States

Trials that died the same way

• EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease
  “Due to low recruitment” (82% match in meaning)
• Whole-body Vibration Physiotherapy in Kidney Transplantation
  “Due to low recruitment rate” (82% match in meaning)
• Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
  “Inadequate recruitment” (80% match in meaning)
• Probiotics and the Prevention of Traveler's Diarrhea
  “because of low rate recruitment and the inability to reach the target expected” (79% match in meaning)
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
  “Due to Poor Recruitment” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.